Clinical trial
Daily Nevirapine to Prevent Mother to Infant Transmission of HIV
NCT00061321 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Completed
Key facts
| NCT number | NCT00061321 |
|---|---|
| Title | Daily Nevirapine to Prevent Mother to Infant Transmission of HIV |
| Official title | Prevention of Maternal to Infant HIV Transmission in India |
| Acronym | SWEN |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Nevirapine and mulitvitamins |
| Enrollment | 770 |
| Start date | Aug 1, 2002 |
| Primary completion | Apr 1, 2007 |
| Completion | Sep 1, 2007 |
| First posted | May 28, 2003 |
| Last update posted | Jul 31, 2008 |
| Countries | India |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: